Tick-borne lymphadenopathy, an emerging disease
Copyright © 2014 Elsevier GmbH. All rights reserved..
Tick-borne lymphadenopathy (TIBOLA) is a spotted fever group disease characterized by an eschar and pronounced enlarged lymph nodes after a scalp tick bite. The goal of this synopsis is to review the TIBOLA literature published until May 2013: Forty-one articles (reporting 537 cases) were included. There was a predominance of cases in females and young people. Spain, France, and Hungary reported the majority of cases, and they were mainly reported in the colder seasons. The involved tick bite was frequently on the scalp. Rickettsia slovaca was the most frequent identified bacterium and Dermacentor marginatus the most frequently identified vector. The most prescribed antibiotic was doxycycline. TIBOLA has the potential to emerge outside Europe: improving knowledge of TIBOLA may promote early symptoms recognition and may allow early treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
---|---|
Enthalten in: |
Ticks and tick-borne diseases - 5(2014), 6 vom: 05. Okt., Seite 656-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Silva-Pinto, André [VerfasserIn] |
---|
Links: |
---|
Themen: |
DEBONEL |
---|
Anmerkungen: |
Date Completed 16.10.2015 Date Revised 15.09.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ttbdis.2014.04.016 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM240688716 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM240688716 | ||
003 | DE-627 | ||
005 | 20231224122634.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ttbdis.2014.04.016 |2 doi | |
028 | 5 | 2 | |a pubmed24n0802.xml |
035 | |a (DE-627)NLM240688716 | ||
035 | |a (NLM)25090977 | ||
035 | |a (PII)S1877-959X(14)00106-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Silva-Pinto, André |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tick-borne lymphadenopathy, an emerging disease |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.10.2015 | ||
500 | |a Date Revised 15.09.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2014 Elsevier GmbH. All rights reserved. | ||
520 | |a Tick-borne lymphadenopathy (TIBOLA) is a spotted fever group disease characterized by an eschar and pronounced enlarged lymph nodes after a scalp tick bite. The goal of this synopsis is to review the TIBOLA literature published until May 2013: Forty-one articles (reporting 537 cases) were included. There was a predominance of cases in females and young people. Spain, France, and Hungary reported the majority of cases, and they were mainly reported in the colder seasons. The involved tick bite was frequently on the scalp. Rickettsia slovaca was the most frequent identified bacterium and Dermacentor marginatus the most frequently identified vector. The most prescribed antibiotic was doxycycline. TIBOLA has the potential to emerge outside Europe: improving knowledge of TIBOLA may promote early symptoms recognition and may allow early treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a DEBONEL | |
650 | 4 | |a Rickettsia infections (MeSH) | |
650 | 4 | |a Rickettsia raoultii | |
650 | 4 | |a Rickettsia slovaca | |
650 | 4 | |a TIBOLA | |
700 | 1 | |a Santos, Maria de Lurdes |e verfasserin |4 aut | |
700 | 1 | |a Sarmento, António |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ticks and tick-borne diseases |d 2010 |g 5(2014), 6 vom: 05. Okt., Seite 656-9 |w (DE-627)NLM198667175 |x 1877-9603 |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2014 |g number:6 |g day:05 |g month:10 |g pages:656-9 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ttbdis.2014.04.016 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 5 |j 2014 |e 6 |b 05 |c 10 |h 656-9 |